Figure 5
Figure 5. Enrichment of MSI cells at relapse. (A) Patient L2: reconstructed lineage tree of CD117+, PB individual leukemia blasts cells at diagnosis (blue) and relapse (red) and CD34+ CD38− CD90+ leukemia stem cells from bone marrow at diagnosis (orange) for patient L2. The dashed red line is the threshold above which cells are designated as MSI. Y-axis represents depth. The scale is the fraction of MSs with mutated allele divided by total number of MSs amplified for each cell. (B) CML blast crisis patient L5: reconstructed lineage tree of CD34+ CD117+ CD33+, from PB, individual leukemia blast cells at diagnosis (blue) and relapse (red) for patient L5. The dashed red line is the threshold above which cells are designated as MSI. Y-axis represents depth. The scale is the fraction of MSs with mutated allele divided by total number of MSs amplified for each cell.

Enrichment of MSI cells at relapse. (A) Patient L2: reconstructed lineage tree of CD117+, PB individual leukemia blasts cells at diagnosis (blue) and relapse (red) and CD34+ CD38 CD90+ leukemia stem cells from bone marrow at diagnosis (orange) for patient L2. The dashed red line is the threshold above which cells are designated as MSI. Y-axis represents depth. The scale is the fraction of MSs with mutated allele divided by total number of MSs amplified for each cell. (B) CML blast crisis patient L5: reconstructed lineage tree of CD34+ CD117+ CD33+, from PB, individual leukemia blast cells at diagnosis (blue) and relapse (red) for patient L5. The dashed red line is the threshold above which cells are designated as MSI. Y-axis represents depth. The scale is the fraction of MSs with mutated allele divided by total number of MSs amplified for each cell.

Close Modal

or Create an Account

Close Modal
Close Modal